New Study in Nature Connects HIF-2α Pathways to Treatment Response in Advanced Kidney Cancer Patients Receiving Casdatifan
Arcus Biosciences, a clinical-stage global biopharmaceutical company, has unveiled groundbreaking data from the ARC-20 study evaluating casdatifan, an investigational small-molecule ...
